TriNetX Summit 2022

October 17-19, 2022
Boston, MA | InterContinental

Where Healthcare Organizations and Industry Meet

TriNetX’s end user conference took place on October 17-19, 2022 at the InterContinental hotel in Boston. The two-day, invitation-only event brought the global community of TriNetX members together to network, share best practices, participate in training, highlight research discoveries and guide the company’s product roadmap including design, enhancements and development timelines.

Photo of the TriNetX Summit event overlooking the speaker stage on the left and the audience seated on the right.

Attendees

Research leaders representing diverse healthcare organizations and pharmaceutical companies from all over the world.

Thought Leaders from Prior Years

Agenda

 

Monday, October 17, 2022

6:00 pm – 9:00 pm EDT

Exhibition and Welcome Reception

The TriNetX Summit commenced on the evening of Monday, October 17th with a welcome reception and exhibition featuring 100+ healthcare organizations from 26 countries and 25+ life sciences companies.

Tuesday, October 18, 2022

7:00 am – 7:30 am EDT

Registration

 

7:30 am – 8:30 am EDT

Networking Breakfast

 

8:30 am – 9:00 am EDT

Opening Address

TriNetX’s chief executive officer discusses the mission of the company and the journey healthcare organizations and life sciences companies have taken to discover the possibilities of real-world data ‘for all mankind.’ Lachman highlights key achievements and growth since the prior Summit and unveils the acquisition of European regulatory-grade real-world evidence leader OncologyInformationService e.K. (OIS) and its subsidiary CancerDataNet GmbH.

Watch Recording

Gadi Lachman, Chief Executive Officer, TriNetX

9:00 am – 10:00 am EDT

TriNetX Product Roadmap, Global RWD, and Future Innovation

It all started with a mission to advance medicine and save lives, but on that journey, we discovered so much more. Hear TriNetX leaders share the latest product developments, the growth in depth and breadth of real-world data powering TriNetX technology, and the evolution of the TriNetX platform from 2019 to present.

Watch Recording

Jesica Freeman, Senior Vice President, Product Management and Marketing, TriNetX

Steve Kundrot, Chief Technology Officer, TriNetX

Brecht Claerhout, Chief Data Officer, TriNetX

10:00 am – 10:30 am EDT

Networking Coffee Break

10:30 am – 11:30 am EDT

Regulatory Strategies for the Future of Real-World Data

Real-world data is growing in importance for regulatory decision-making. This discussion will centralize on lessons learned from thought leaders working with regulatory agencies and the opportunities that lie ahead for assessment of data sources, fit-for-purpose, and transparency for internal decision-making and regulatory submissions. Learn how decision-makers are increasing their trust in proxies when complete verification of real-world data definitions is infeasible, and in what circumstances they are most applicable.

Watch Recording

Jeffrey Brown, Chief Scientific Officer, TriNetX

Rachele Hendricks-Sturrup, Research Director, Real World Evidence, Duke-Robert J. Margolis, MD, Center for Health Policy

Solomon Iyasu, MD, MPH, FISPE, Principal, Iyasu Epi-RWE Strategy LLC

Lenka Kellermann, Owner, OncologyInformationService e.K.

Sébastien Wischlen, Chief Executive Officer, CancerDataNet GmbH

11:30 am – 1:00 pm EDT

Networking Lunch

1:00 pm – 1:55 pm EDT

Introduction to LUCID, the TriNetX On-Platform Data Science Coding Environment

As real-world data has exploded, so has data analysis. The need to identify, license, stage, and explore custom fit data along a fast and collaborative workflow has never been greater. But it’s remained a gap in our field, until now. LUCID is our new data science environment for coding, visualizing, and collaborating, equipped with the full range of features you’ve come to expect from today’s “data notebook” experiences. Best of all, LUCID is seamlessly connected to our LIVE networks, so you can build your cohort and stage the underlying data in a single end-to-end process. Learn how to reduce your “time to evidence” from months to days, even hours. Following a demo, we’ll hear from our regulatory, HEOR and market access leadership on how this streamlined path to real-world evidence could impact everything from submissions to payor negotiations.

Watch Recording

Jeff Graham, Vice President, Real-World Data and Innovation, TriNetX

Daniel Liu, MD, Assistant Professor, University of Arkansas for Medical Sciences and Arkansas Children’s Hospital

Justin North, Director, Product Management, TriNetX

2:00 pm – 3:00 pm EDT

Breakout Sessions

A. Best Practices in Data Expansion and Enrichment
Liberating real-world data is a journey, and this session focuses on data sourcing principles, data quality and fit-for-purpose, tokenization and linking. Thought leaders discuss how they prioritize data expansion and enrichment projects at their healthcare organization, the level of effort to bring data sources to bear, how social determinants of health (SDoH) have been leveraged to date, and how they have successfully navigated the barriers to bringing real-world data to bear for clinical and translational research.

Watch Recording

Brecht Claerhout, Chief Data Officer, TriNetX

Maggie Berryman, Vice President, Global Data Engineering, TriNetX

Matvey Palchuk, MD, MS, FAMIA, Vice President, Informatics, TriNetX

Michael Swartzbaugh, Sr. Director, Product Management, TriNetX

Pablo Serrano Balazote, Chief Planning Officer, Hospital Universitario 12 de Octubre

Maurice Tut, Senior Project Manager,Children’s Hospital Los Angeles

Brad Taylor, Chief Research Informatics Officer, Medical College of Wisconsin

B. Publishing with TriNetX Real-World Data

Generating real-world evidence for peer-reviewed publication is of paramount importance to the TriNetX community. In this session, you will attain guidance on the use of TriNetX real-world data for this purpose, as well as hear from three researchers who presented studies that were successfully published utilizing the TriNetX platform and data.

Watch Recording

Sierra Luciano, Manager, Clinical Feasibility and Analytics, TriNetX

Sarju Ganatra, MD, FACC, FICOS, Director – Cardio-Oncology Program, Lahey Hospital and Medical Center

Ram Gouripeddi, Assistant Professor, Department of Biomedical Informatics, Assistant Director of Informatics, Clinical and Translational Science Institute, Associate Director for Research, Center of Excellence for Exposure Health Informatics, University of Utah

Gema Hernández Ibarburu, Healthcare Partnership Manager EMEA, TriNetX

3:00 pm – 3:30 pm EDT

Networking Coffee Break

3:30 pm – 4:30 pm EDT

Addressing Research Challenges with Diversity and Inclusion

Diversity is a moral and scientific issue in clinical research. Hear members of the TriNetX community discuss the importance and efforts undertaken to reduce bias, promote social equity and empowerment, and produce innovative science informed by a representative population of patients that will ultimately receive treatment.

Watch Recording

Josh Hartman, Director, Clinical Feasibility and Analytics, TriNetX

Bill Adams, MD, Professor of Pediatrics, Boston University School of Medicine

Laura Doremus, Global Health Insights Associate Director, D&I, Novartis

Vesna Rysdale, Senior Director, Global Strategic Feasibility, PPD

Janel Titus, Real-World Data Engagement Lead, Takeda

7:00 pm – 10:00 pm EDT

Cocktail Reception and Entertainment

Wednesday, October 19, 2022

8:00 am – 9:00 am EDT

Networking Breakfast

9:00 am – 10:00 am EDT

Breakout Sessions

C. Oncology Think Tank

Cancer touches everyone, and real-world data fuels innovation. However, in oncology real-world data is abundant yet disjointed and complex. Hear oncology experts from across the TriNetX community as they brainstorm ideas to improve our collective understanding and use of real-world data to support patients on their cancer journey.

Watch Recording

Jim Phillips, Vice President, Account Management, TriNetX

Saurin Jani, Associate Director, RWD Partnerships and Innovation Lead, Takeda

Lenka Kellermann, Owner, OncologyInformationService e.K.

Samantha Shaw, Director of Product Management, TriNetX

D. Innovative Use Cases for the TriNetX Platform and Real-World Data Sets

Thanks to the global TriNetX community, we can all study real-world data that is recent, a mile wide, and a mile deep. This session explores innovative applications of real-world data to improve patient safety, machine learning and predictive modeling for the early detection of patients at risk for developing pancreatic cancer, and the usefulness of prospective monitoring and following of cohorts to understand outcomes on a go forward basis.

Watch Recording

Bryan Farrow, Senior Director, Product Marketing, TriNetX

Limor Appelbaum, MD, Staff Scientist, Department of Radiation Oncology, Beth Israel Deaconess Medical Center

Andrea Demakas, Director, Enterprise Sales, TriNetX

Justin North, Director, Product Management, TriNetX

10:00 am – 10:30 am EDT

Networking Coffee Break

10:30 am – 11:30 am EDT

Improving Efficiency and Collaboration for Clinical Trial and Chart Review Opportunities

Clinical trials and chart reviews might appear to be an unlikely pairing; however they share commonalities for the TriNetX community. Pharmaceutical companies utilize the TriNetX platform and real-world data to collaborate with healthcare organizations that have eligible patients for both clinical trial and chart review opportunities. Hear thought leaders from both sides as they discuss opportunities to improve execution and collaboration across these studies.

Watch Recording

Jennifer Stacey, Senior Vice President, Clinical Sciences and Operations, TriNetX

Jeffrey Brown, Chief Scientific Officer, TriNetX

Sandra Dodd, Site Liaison Director, Clinical Trials Network of Tennessee

Jen Poon, Real-World Data Solutions Director, PAREXEL

11:30 am – 12:00 pm EDT

Closing Remarks

Gadi Lachman, Chief Executive Officer, TriNetX

 

12:00 pm – 1:30 pm EDT

Networking Lunch

Location

InterContinental
510 Atlantic Ave.
Boston, MA 02210

The Boston waterfront’s latest landmark, the InterContinental Hotel reflects graceful modern design, recognized for quality by Forbes and AAA as a four-star destination with stunning views, dining and accommodations on Boston harbor.

TriNetX Summit Recordings

Watch sessions and experience the innovation and excitement of the 2022 TriNetX Summit.

Contact Us